<p>FCDO is currently working with implementing partners, drug companies, donors and the World Health Organisation (WHO) to identify critical and immediate activities that we are able to fund and to manage exit from the ASCEND programme. It is not possible at this stage to say if any of the 24 recipient countries will face disruptions to delivery of medicines. We are, however, communicating with Ministries of Health and national Neglected Tropical Diseases (NTD) programmes to consider where gaps can be covered and prioritise activities. We are also continuing to distribute drugs to fight NTDs and perform surgeries in the most urgent cases.</p><p>Global health remains a top priority for UK Official Development Assistance (ODA) and we will continue to be a major contributor in leading international action to strengthen global health security and help build more resilient health systems. Departmental cross-government allocations of ODA spend for 2021/22 were laid out in a Written Ministerial Statement in Parliament on 21 April and the Foreign Secretary highlighted that FCDO will spend £1,305 million on global health, which means that we will remain among the most generous international donors.</p>